Clinical validity of increased cortical uptake of [(18)F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework

PURPOSE: In 2017, the Geneva Alzheimer’s disease (AD) Biomarker Roadmap initiative adapted the framework of the systematic validation of oncological diagnostic biomarkers to AD biomarkers, with the aim to accelerate their development and implementation in clinical practice. With this work, we assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolters, E. E., Dodich, A., Boccardi, M., Corre, J., Drzezga, A., Hansson, O., Nordberg, A., Frisoni, G. B., Garibotto, V., Ossenkoppele, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175307/
https://www.ncbi.nlm.nih.gov/pubmed/33547556
http://dx.doi.org/10.1007/s00259-020-05118-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175307/
https://www.ncbi.nlm.nih.gov/pubmed/33547556
http://dx.doi.org/10.1007/s00259-020-05118-w

Ejemplares similares